Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Geron cuts 20 jobs, awaits imetelstat investigator results

This article was originally published in Scrip

Executive Summary

Geron has eliminated its drug discovery research and companion diagnostic programs, and reduced its work force by another 20 employees, and now the company's path forward depends solely on the results of an investigator-sponsored study for its lone drug candidate imetelstat in a single hematological indication.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC021209

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel